The following courses have been part of Michael's teaching responsibilities since 1996. Until 2005, they were offered through the Institute for Research & Development at the University of Witten/Herdecke, Germany. Since 2005, they have been held at the University of Duisburg-Essen. Current students may access selected materials in the respective password-protected download areas.

The courses ("modules") taught at the University of Duisburg-Essen are part of an innovative two-year Postgraduate Study Program in Pharmaceutical Medicine designed to introduce students to the complex process of new product development in the international pharmaceutical industry. Since its inception in 1996, Michael has been involved by

  • Serving, as a member of the Faculty of Medicine of the Witten/Herdecke University (since 2005, at the University of Duisburg-Essen), on the Scientific Steering Committee of the program, and
  • Serving as the Head Lecturer of Module 2
    and Module 12 of the program.

Module 2: Working in a Complex Organization

                          (with emphasis on Innovation Management)

Overview:

Topics covered include: organizational theory and design: organizations as complex systems, adapting to environmental uncertainty, organizational goals and effectiveness criteria, value-based management, the principal-agent model, organizational size and life cycle, bureaucracy, organizational structures, managing innovation and change; organizational behavior: attitudes, values, personality, foundations of motivation theories, leadership, power, politics, and communication in organizations; managing complex projects: groups and teams, principles of project management, decision-making in the horizontal organization, heavyweight teams; case studies.

Grading:

Module assessment will be based on

  • Grading of students' homework assignment (15%)
  • Class participation (25%)
  • Presentations / teamwork (30%)
  • Midterm examination (10%)
  • Final examination (20%)

For further information on individual and team assignments and on grading, students are asked to consult the module syllabus and time schedule.

Readings:

Handouts:

  • Students are provided with a comprehensive Reader four weeks ahead of class sessions.
  • Additional materials are accessable for download.
  • Further texts will be mentioned and recommended throughout the module.

Required Reading:

  • Students are expected to have read the Reader in advance of class sessions.

Recommended Reading:

  • Christensen, Clayton M. (2000):
    The Innovator's Dilemma. New York, NY: Harper.
  • Daft, Richard L. (7th ed., 2001): Organization Theory and Design. Mason, Ohio: South-Western/Thomson.
  • Kerzner, Harold (2001): Strategic Planning for Project Management Using a Project Maturity Model.
    New York, NY: Wiley.
  • Kotter, John P. (1996): Leading Change. Boston, Mass.: Harvard Business School Press.
  • Robbins, Stephen R. (7th ed., 1995): Organizational Behavior - Concepts, Controversies, Applications. Englewood Cliffs, NJ: Prentice Hall.
  • Scott-Morgan, Peter (1994): The Unwritten Rules of the Game. New York, NY: McGraw-Hill.
  • Spilker, Bert (2nd ed., 1994): Multinational Pharmaceutical Companies: Principles and Practices. New York , NY: Raven.
  • Tushman, Michael L., and O'Reilly III, Charles A. (1997): Winning Through Innovation: A Practical Guide to Leading Organizational Change and Renewal. Boston, Mass.: Harvard Business School Press.
  • Wheelwright, Steven C., and Clark, Kim B. (1992): Revolutionizing Product Development:
    Quantum Leaps in Speed, Efficiency, and Quality.
    New York, NY: The Free Press.

On the Web:

  • pdma - Product Development & Management Association
  • DIA - Drug Information Association
  • CMR International - Centre for Medicines Research International Ltd.
  • Tufts Center for the Study of Drug Development affiliated with Tufts University, Boston, Mass.
  • PhRMA - Pharmaceutical Research and Manufacturers of America
  • EFPIA - European Federation of Pharmaceutical Industries and Associations
  • EGA - European Generic Medicines Association
  • VFA - Verband forschender Arzneimittelhersteller - German Association of Research-Based Pharmaceutical Companies

Student Area:

For access please click here.                                            upward

 


Module 12: Health Economics

Overview:

Topics covered include: International health care spending trends, market environment, health care reform and regulation; cost-containment and the ethics of rationing mechanisms; spending decisions by patients, physicians, and third-party payers; costing theory & analysis; resource valuation; cost-benefit analysis (CBA) and its theoretical foundations; cost-effectiveness analysis (CEA) and cost-utility analysis (CUA); interpreting cost-effectiveness claims; the decision rules of CEA; theoretical foundations of CUA, measuring values and utilities, quality-adjusted life years (QALYs) and alternative outcome measures; a typology of outcomes instruments; the reference case in health economic analyses; study designs and data sources in health economics; modeling in health economics and sensitivity analyses; implications of different perspectives, international guidelines and international transfer of data; international pricing strategies for pharmaceutical products.

Grading:

Module assessment will be based on:

  • Grading of students’ homework assignment (20%)
  • Class participation (20%)
  • Presentations / teamwork (20%)
  • Midterm examination (10%)
  • Final examination (30%)

For further information on individual and team assignments and on grading, students are asked to consult the module syllabus and time schedule.

Readings:

Handouts:

  • Students are provided with a comprehensive Reader four weeks ahead of class sessions.
  • Additional materials are accessible for download.
  • Further texts will be mentioned and recommended throughout the module.

Required Reading:

  • Students are expected to have read the Reader in advance of class sessions.

Recommended Reading:

  • Barer, Morris L., Getzen, Thomas E., Stoddart, Greg L. (eds.) (1998): Health, Health Care and Health Economics. Perspectives on Distribution.
    Chichester: Wiley.
  • Brent, Robert J. (2003): Cost-Benefit Analysis and Health Care Evaluations. Cheltenham, Northamton, Mass.: Edward Elgar.
  • Drummond, Michael F., Sculpher, Mark J., Torrance, George W., O’Brien, Bernie O., and Stoddart, Greg L. (3rd ed., 2005): Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press.
  • Getzen, Thomas E. (2nd ed., 2004): Health Economics – Fundamentals and Flow of Funds. New York, NY: Wiley.
  • Gold, Marthe R., Siegel, Joanna E., Russell, Louise B., and Weinstein, Milton C. (1996):
    Cost-Effectiveness in Health and Medicine.
    New York, Oxford: Oxford University Press.
  • Nord, Erik (1999): Cost-Value Analysis in Health Care: Making Sense out of QALYs.
    Cambridge: Cambridge University Press.
  • Schlander, Michael (1998): The Contribution of Health Economics to Market-Oriented Pharmaceutical Research and Development.
    Witten: Universität Witten/Herdecke.
  • Ubel, Peter A. (2001): Pricing Life: Why It’s Time for Health Care Rationing.
    Cambridge, Mass.: Bradford / MIT.
  • Health Affairs, Vol. 23, Number 1 (January/February 2004): Drug Industry: A Closer Look (various papers)

On the Web:

  • AHRQ - Agency for Healthcare Research and Quality
  • NIHCM - National Institute for Health Care Management, a non-profit research and educational foundation in Washington D.C.
  • CADTH - Canadian Agency for Drugs and Technologies in Health (formerly known as CCOHTA, Canadian Coordinating Office for Health Technology Assessment )
  • NICE - National Institute of Health and Clinical Excellence
  • INAHTA - International Network of Agencies for Health Technology Assessment
  • OHE - Office of Health Economics: research and consulting in health economics by an institute
    funded by the ABPI
  • iHEA - International Health Economics Association
  • ISPOR - International Society for Pharmacoeconomics and Outcomes Research
  • PhRMA - Pharmaceutical Research and Manufacturers of America
  • EFPIA - European Federation of Pharmaceutical Industries and Associations
  • EGA - European Generic Medicines Association
  • ABPI - Association of the British Pharmaceutical Industry
  • VFA - Verband forschender Arzneimittelhersteller
    - German Association of Research-Based Pharmaceutical Companies

Student Area:

For access, please click here.                                            upward